Figure 4.

Percentages of apoptotic CP-18821 Barrett's esophagus-derived cells after treatment with FXR (4A) or VDR (4B) ligands, as measured by flow cytometry.

De Gottardi et al. Molecular Cancer 2006 5:48   doi:10.1186/1476-4598-5-48
Download authors' original image